Abstract:
Introduction: Hyaline eosinophilic astrocytic inclusion
(HEAI) is a rare histological finding in cases with drugresistant
epilepsy (DRE).
Objectives: To describe two cases of DRE with HEAI
and review the literature.
Patients and Methods: Case 1: A 5-year-old boy with a
history of DRE since 5 months of age and global developmental
delay, nonverbal (GDD, NV). MRI revealed signs
of polymicrogyria, involving the right frontal operculum
with an abnormal cortical folding and rotation pattern.
The genetic panel showed a variant of uncertain significance
in the SCL2A1 gene. Outcome: Engel IV-B. Case 2:
A 5-year-old boy with a history of DRE since 4 months of
age and GDD, NV. MRI showed abnormal cortical folding
and cortical thickening in the right frontal lobe.
Genetic testing demonstrated a variant of uncertain significance
in the ADAR gene. Outcome: Engel IV-A. Resection
of the lesion was performed in both patients.
Results: Both cases showed brightly eosinophilic structures
within the astrocytic cytoplasm in the gray matter and
FCD type 2A. The inclusions were negative with PAS and
Congo red. By immunohistochemistry, they were positive
for S100 and negative for vimentin, and GFAP. We also
analyzed the data of all the previously reported cases.
Conclusion: HEAI is a rare entity, with only 53 cases
reported, including our cases. Evaluating all the cases,
the average age at seizure onset of pediatric patients
(n = 48) was 7 months, without sex predilection. Seven
patients had Aicardi syndrome, and 23 patients presented
GDD. Seizures were observed in 47 patients. Outcome
Engel: I in 10 cases, II in 5, III in 9, and IV in 9. Most
cases involved the frontal lobe (n = 40). HEAIs were positive
for S100 in 21/25 (84%), filamin in 22/25 (88%),
GFAP in 3/32 cases (9%), vimentin in 1/16 (6%), and
PAS in 3/21 (14%). FCD was observed in 19/50 patients
(38%). The significance of HEAI is not clear. Genetic
studies of the surgical specimens will probably allow a
better comprehension of this entity.